Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 18279044.
- Also identified by DOI 10.1086/528859.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Symptoms and quality of life were assessed among human immunodeficiency virus (HIV)-infected individuals initiating their first course of antiretroviral therapy. Symptoms, which were mostly mild or moderate, were common in the first year and significantly affected the patients' quality of life. Quality of life was inversely related to the number of symptoms and in the change in the number of symptoms from baseline.
Medical subject headings
- Anti-HIV Agents
- HIV Infections
- HIV-1
- Quality of Life
- Reverse Transcriptase Inhibitors